| Mckenzie Oral And Facial Surgery Pllc | |
|
445 Henslee Dr Dickson TN 37055-2166 | |
| (615) 441-1441 | |
| (615) 441-1460 |
| Full Name | Mckenzie Oral And Facial Surgery Pllc |
|---|---|
| Speciality | Dentist |
| Location | 445 Henslee Dr, Dickson, Tennessee |
| Authorized Official Name and Position | William Stuart Mckenzie (OWNER) |
| Authorized Official Contact | 6154411441 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Mckenzie Oral And Facial Surgery Pllc 445 Henslee Dr Dickson TN 37055-2166 Ph: (615) 441-1441 | Mckenzie Oral And Facial Surgery Pllc 445 Henslee Dr Dickson TN 37055-2166 Ph: (615) 441-1441 |
| NPI Number | 1922568666 |
|---|---|
| Provider Enumeration Date | 03/20/2019 |
| Last Update Date | 08/26/2021 |
| Medicare PECOS PAC ID | 5991038523 |
|---|---|
| Medicare Enrollment ID | O20190612003692 |
News Archive
In recognition of September's designation as National Pain Awareness Month, the American Society of Interventional Pain Physicians (ASIPP) today announced that it is planning a month-long educational campaign to improve the quality of life for the approximately 75 million Americans suffering from acute and chronic pain.
Like a bridge that spans a river to connect two major metropolises, the corpus callosum is the main conduit for information flowing between the left and right hemispheres of our brains. Now, neuroscientists at the California Institute of Technology have found that people who are born without that link-a condition called agenesis of the corpus callosum, or AgCC-still show remarkably normal communication across the gap between the two halves of their brains.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., a Nevada Corporation, has been sued by Teva Women's Health, Inc., in connection with the filing of Watson's Abbreviated New Drug Application (ANDA) for synthetic conjugated estrogens, A, in the 0.3 mg, 0.45 mg, 0.625 mg, 0.9 mg and 1.25 mg tablet strengths. Watson's ANDA is for the generic equivalent of Teva's Cenestin®. The suit was filed on April 23, 2010, in the United States District Court for the District of New Jersey.
Along with skeletal muscles, it may be important to monitor heart function in patients with spinal muscular atrophy (SMA). These are the findings from a study conducted by Nationwide Children's Hospital and published online ahead of print in Human Molecular Genetics. This is the first study to report cardiac dysfunction in mouse models of SMA.
SuppreMol GmbH, a privately held biopharmaceutical company developing innovative therapeutics for the treatment of autoimmune diseases, today announced that it has successfully completed a pre-Investigational New Drug Application (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) for its lead compound SM101, which is being developed for the treatment of Primary Immune Thrombocytopenia (ITP) and Systemic Lupus Erythematosus (SLE).
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922568666 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223S0112X | Dentist - Oral And Maxillofacial Surgery | (* (Not Available)) | Primary |
| Provider Name | William Stuart Mckenzie |
|---|---|
| Provider Type | Practitioner - Maxillofacial Surgery |
| Provider Identifiers | NPI Number: 1932427317 PECOS PAC ID: 8628214343 Enrollment ID: I20160902000449 |
News Archive
In recognition of September's designation as National Pain Awareness Month, the American Society of Interventional Pain Physicians (ASIPP) today announced that it is planning a month-long educational campaign to improve the quality of life for the approximately 75 million Americans suffering from acute and chronic pain.
Like a bridge that spans a river to connect two major metropolises, the corpus callosum is the main conduit for information flowing between the left and right hemispheres of our brains. Now, neuroscientists at the California Institute of Technology have found that people who are born without that link-a condition called agenesis of the corpus callosum, or AgCC-still show remarkably normal communication across the gap between the two halves of their brains.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., a Nevada Corporation, has been sued by Teva Women's Health, Inc., in connection with the filing of Watson's Abbreviated New Drug Application (ANDA) for synthetic conjugated estrogens, A, in the 0.3 mg, 0.45 mg, 0.625 mg, 0.9 mg and 1.25 mg tablet strengths. Watson's ANDA is for the generic equivalent of Teva's Cenestin®. The suit was filed on April 23, 2010, in the United States District Court for the District of New Jersey.
Along with skeletal muscles, it may be important to monitor heart function in patients with spinal muscular atrophy (SMA). These are the findings from a study conducted by Nationwide Children's Hospital and published online ahead of print in Human Molecular Genetics. This is the first study to report cardiac dysfunction in mouse models of SMA.
SuppreMol GmbH, a privately held biopharmaceutical company developing innovative therapeutics for the treatment of autoimmune diseases, today announced that it has successfully completed a pre-Investigational New Drug Application (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) for its lead compound SM101, which is being developed for the treatment of Primary Immune Thrombocytopenia (ITP) and Systemic Lupus Erythematosus (SLE).
› Verified 5 days ago
| Provider Name | Matthew Mclaughlin |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1144614991 PECOS PAC ID: 2365750122 Enrollment ID: I20210909003088 |
News Archive
In recognition of September's designation as National Pain Awareness Month, the American Society of Interventional Pain Physicians (ASIPP) today announced that it is planning a month-long educational campaign to improve the quality of life for the approximately 75 million Americans suffering from acute and chronic pain.
Like a bridge that spans a river to connect two major metropolises, the corpus callosum is the main conduit for information flowing between the left and right hemispheres of our brains. Now, neuroscientists at the California Institute of Technology have found that people who are born without that link-a condition called agenesis of the corpus callosum, or AgCC-still show remarkably normal communication across the gap between the two halves of their brains.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., a Nevada Corporation, has been sued by Teva Women's Health, Inc., in connection with the filing of Watson's Abbreviated New Drug Application (ANDA) for synthetic conjugated estrogens, A, in the 0.3 mg, 0.45 mg, 0.625 mg, 0.9 mg and 1.25 mg tablet strengths. Watson's ANDA is for the generic equivalent of Teva's Cenestin®. The suit was filed on April 23, 2010, in the United States District Court for the District of New Jersey.
Along with skeletal muscles, it may be important to monitor heart function in patients with spinal muscular atrophy (SMA). These are the findings from a study conducted by Nationwide Children's Hospital and published online ahead of print in Human Molecular Genetics. This is the first study to report cardiac dysfunction in mouse models of SMA.
SuppreMol GmbH, a privately held biopharmaceutical company developing innovative therapeutics for the treatment of autoimmune diseases, today announced that it has successfully completed a pre-Investigational New Drug Application (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) for its lead compound SM101, which is being developed for the treatment of Primary Immune Thrombocytopenia (ITP) and Systemic Lupus Erythematosus (SLE).
› Verified 5 days ago
| Provider Name | Kyle Diluzio |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1548622632 PECOS PAC ID: 3173810918 Enrollment ID: I20220728000407 |
News Archive
In recognition of September's designation as National Pain Awareness Month, the American Society of Interventional Pain Physicians (ASIPP) today announced that it is planning a month-long educational campaign to improve the quality of life for the approximately 75 million Americans suffering from acute and chronic pain.
Like a bridge that spans a river to connect two major metropolises, the corpus callosum is the main conduit for information flowing between the left and right hemispheres of our brains. Now, neuroscientists at the California Institute of Technology have found that people who are born without that link-a condition called agenesis of the corpus callosum, or AgCC-still show remarkably normal communication across the gap between the two halves of their brains.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., a Nevada Corporation, has been sued by Teva Women's Health, Inc., in connection with the filing of Watson's Abbreviated New Drug Application (ANDA) for synthetic conjugated estrogens, A, in the 0.3 mg, 0.45 mg, 0.625 mg, 0.9 mg and 1.25 mg tablet strengths. Watson's ANDA is for the generic equivalent of Teva's Cenestin®. The suit was filed on April 23, 2010, in the United States District Court for the District of New Jersey.
Along with skeletal muscles, it may be important to monitor heart function in patients with spinal muscular atrophy (SMA). These are the findings from a study conducted by Nationwide Children's Hospital and published online ahead of print in Human Molecular Genetics. This is the first study to report cardiac dysfunction in mouse models of SMA.
SuppreMol GmbH, a privately held biopharmaceutical company developing innovative therapeutics for the treatment of autoimmune diseases, today announced that it has successfully completed a pre-Investigational New Drug Application (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) for its lead compound SM101, which is being developed for the treatment of Primary Immune Thrombocytopenia (ITP) and Systemic Lupus Erythematosus (SLE).
› Verified 5 days ago
News Archive
In recognition of September's designation as National Pain Awareness Month, the American Society of Interventional Pain Physicians (ASIPP) today announced that it is planning a month-long educational campaign to improve the quality of life for the approximately 75 million Americans suffering from acute and chronic pain.
Like a bridge that spans a river to connect two major metropolises, the corpus callosum is the main conduit for information flowing between the left and right hemispheres of our brains. Now, neuroscientists at the California Institute of Technology have found that people who are born without that link-a condition called agenesis of the corpus callosum, or AgCC-still show remarkably normal communication across the gap between the two halves of their brains.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., a Nevada Corporation, has been sued by Teva Women's Health, Inc., in connection with the filing of Watson's Abbreviated New Drug Application (ANDA) for synthetic conjugated estrogens, A, in the 0.3 mg, 0.45 mg, 0.625 mg, 0.9 mg and 1.25 mg tablet strengths. Watson's ANDA is for the generic equivalent of Teva's Cenestin®. The suit was filed on April 23, 2010, in the United States District Court for the District of New Jersey.
Along with skeletal muscles, it may be important to monitor heart function in patients with spinal muscular atrophy (SMA). These are the findings from a study conducted by Nationwide Children's Hospital and published online ahead of print in Human Molecular Genetics. This is the first study to report cardiac dysfunction in mouse models of SMA.
SuppreMol GmbH, a privately held biopharmaceutical company developing innovative therapeutics for the treatment of autoimmune diseases, today announced that it has successfully completed a pre-Investigational New Drug Application (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) for its lead compound SM101, which is being developed for the treatment of Primary Immune Thrombocytopenia (ITP) and Systemic Lupus Erythematosus (SLE).
› Verified 5 days ago
Charter Oak Endodontics, Inc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1926 Highway 46 S, Dickson, TN 37055 Phone: 615-446-7050 | |
Tennessee Oral & Maxillofacial Surgeons Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 502 E College St, Dickson, TN 37055 Phone: 615-446-9669 Fax: 615-446-9661 | |
Maximize Oral Surgery Management Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 445 Henslee Dr, Dickson, TN 37055 Phone: 615-441-1441 | |
Richland Creek Dental Group, Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 102 Highway 70 E Ste 2, Dickson, TN 37055 Phone: 154-464-6446 | |
Accent Smile Center Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 320 E College St, Suite A, Dickson, TN 37055 Phone: 615-740-7645 Fax: 615-740-0245 | |
Sleep Well Dickson Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 320 E College St Ste A, Dickson, TN 37055 Phone: 615-740-7645 | |
Dickson Dental Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1926 Hwy 46 S, Dickson, TN 37055 Phone: 615-446-7050 Fax: 615-446-4699 |